Plant-derived vaccines: A look back at the highlights and a view to the challenges on the road ahead

Yasmin Thanavala, Zhong Huang, Hugh Mason

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The sobering reality is that each year, 33 million children remain unvaccinated for vaccine-preventable diseases. Universal childhood vaccination would have profound effects on leveling the health inequities in many parts of the world. As an alternative to administration of vaccines by needle and syringe, oral vaccines offer significant logistical advantages, as the polio eradication campaign has demonstrated. Over the past decade, the expression of subunit vaccine antigens in plants has emerged as a convenient, safe and potentially economical platform technology, with the potential to provide a novel biotechnological solution to vaccine production and delivery. As this technology has come of age, many improvements have been made on several fronts, as a growing number of research groups worldwide have extensively investigated plants as factories for vaccine production. This review attempts to highlight some of the achievements over the past 15 years, identify some of the potential problems and discuss the promises that this technology could fulfill.

Original languageEnglish (US)
Pages (from-to)249-260
Number of pages12
JournalExpert Review of Vaccines
Volume5
Issue number2
DOIs
StatePublished - 2006

Fingerprint

Vaccines
Technology
Plant Antigens
Subunit Vaccines
Syringes
Poliomyelitis
Needles
Vaccination
Health
Research

Keywords

  • Immune response
  • Mucosal vaccine
  • Oral immunization
  • Transgenic plants

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Plant-derived vaccines : A look back at the highlights and a view to the challenges on the road ahead. / Thanavala, Yasmin; Huang, Zhong; Mason, Hugh.

In: Expert Review of Vaccines, Vol. 5, No. 2, 2006, p. 249-260.

Research output: Contribution to journalArticle

@article{6cb38ba6652b4a458ac3ac47d2596275,
title = "Plant-derived vaccines: A look back at the highlights and a view to the challenges on the road ahead",
abstract = "The sobering reality is that each year, 33 million children remain unvaccinated for vaccine-preventable diseases. Universal childhood vaccination would have profound effects on leveling the health inequities in many parts of the world. As an alternative to administration of vaccines by needle and syringe, oral vaccines offer significant logistical advantages, as the polio eradication campaign has demonstrated. Over the past decade, the expression of subunit vaccine antigens in plants has emerged as a convenient, safe and potentially economical platform technology, with the potential to provide a novel biotechnological solution to vaccine production and delivery. As this technology has come of age, many improvements have been made on several fronts, as a growing number of research groups worldwide have extensively investigated plants as factories for vaccine production. This review attempts to highlight some of the achievements over the past 15 years, identify some of the potential problems and discuss the promises that this technology could fulfill.",
keywords = "Immune response, Mucosal vaccine, Oral immunization, Transgenic plants",
author = "Yasmin Thanavala and Zhong Huang and Hugh Mason",
year = "2006",
doi = "10.1586/14760584.5.2.249",
language = "English (US)",
volume = "5",
pages = "249--260",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Plant-derived vaccines

T2 - A look back at the highlights and a view to the challenges on the road ahead

AU - Thanavala, Yasmin

AU - Huang, Zhong

AU - Mason, Hugh

PY - 2006

Y1 - 2006

N2 - The sobering reality is that each year, 33 million children remain unvaccinated for vaccine-preventable diseases. Universal childhood vaccination would have profound effects on leveling the health inequities in many parts of the world. As an alternative to administration of vaccines by needle and syringe, oral vaccines offer significant logistical advantages, as the polio eradication campaign has demonstrated. Over the past decade, the expression of subunit vaccine antigens in plants has emerged as a convenient, safe and potentially economical platform technology, with the potential to provide a novel biotechnological solution to vaccine production and delivery. As this technology has come of age, many improvements have been made on several fronts, as a growing number of research groups worldwide have extensively investigated plants as factories for vaccine production. This review attempts to highlight some of the achievements over the past 15 years, identify some of the potential problems and discuss the promises that this technology could fulfill.

AB - The sobering reality is that each year, 33 million children remain unvaccinated for vaccine-preventable diseases. Universal childhood vaccination would have profound effects on leveling the health inequities in many parts of the world. As an alternative to administration of vaccines by needle and syringe, oral vaccines offer significant logistical advantages, as the polio eradication campaign has demonstrated. Over the past decade, the expression of subunit vaccine antigens in plants has emerged as a convenient, safe and potentially economical platform technology, with the potential to provide a novel biotechnological solution to vaccine production and delivery. As this technology has come of age, many improvements have been made on several fronts, as a growing number of research groups worldwide have extensively investigated plants as factories for vaccine production. This review attempts to highlight some of the achievements over the past 15 years, identify some of the potential problems and discuss the promises that this technology could fulfill.

KW - Immune response

KW - Mucosal vaccine

KW - Oral immunization

KW - Transgenic plants

UR - http://www.scopus.com/inward/record.url?scp=33746725964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746725964&partnerID=8YFLogxK

U2 - 10.1586/14760584.5.2.249

DO - 10.1586/14760584.5.2.249

M3 - Article

C2 - 16608424

AN - SCOPUS:33746725964

VL - 5

SP - 249

EP - 260

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 2

ER -